ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway

BACKGROUND: Breast cancer angiogenesis is key for metastasis and predicts a poor prognosis. Angiotensin-converting enzyme 2 (ACE2), as a member of the renin-angiotensin system (RAS), was reported to restrain the progression of hepatocellular carcinoma (HCC) and non-small cell lung cancer (NSCLC) thr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qi, Lu, Sihong, Li, Tianfu, Yu, Liang, Zhang, Yunjian, Zeng, Huijuan, Qian, Xueke, Bi, Jiong, Lin, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482513/
https://www.ncbi.nlm.nih.gov/pubmed/31023337
http://dx.doi.org/10.1186/s13046-019-1156-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482513/
https://www.ncbi.nlm.nih.gov/pubmed/31023337
http://dx.doi.org/10.1186/s13046-019-1156-5

Ejemplares similares